Status:

COMPLETED

MAKO-Uni-Knee Arthroplasty Clinical Outcomes and Function

Lead Sponsor:

Foundation for Orthopaedic Research and Education

Collaborating Sponsors:

Stryker Orthopaedics

Conditions:

Clinical Outcomes

Eligibility:

All Genders

21-100 years

Phase:

NA

Brief Summary

This study represents a single-surgeon/institution, non-randomized, consecutive series, prospective and comparative cohort design. The Principal Investigator is anticipating 100 study patients in the ...

Detailed Description

To compare functional and clinical outcomes in patients with and without intact Anterior Cruciate Ligament undergoing uni-compartmental knee arthroplasty with MAKOplasty Robotic-Arm Assisted Surgery. ...

Eligibility Criteria

Inclusion

  • Subjects must meet these criteria to participate in this study:
  • Patients with isolated, symptomatic femorotibial knee arthritis and candidates for UKA;
  • Patients ≥ 21 years old;
  • Patients with intact and non-functional ACLs as determined through pre-operative imaging, knee laxity tests, rotational stability tests, and intraoperative ACL classification;
  • Patients willing and able to sign an informed consent;
  • Patients willing and able to comply with 2-year follow-up commitments.

Exclusion

  • Any subject who meets any of the exclusion criteria will be excluded from participation in this study:
  • Patients with RA;
  • Patients with BMI \>40;
  • Patients with ROM arc \> 75°;
  • Patients with greater than 10º of hyperextension;
  • Patients with greater than 15º of varus or valgus deformity;
  • Patients with active infection;
  • Patients without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis;
  • Patients without sufficient soft tissue integrity to provide adequate stability;
  • Patients with either mental or neuromuscular disorders that do not allow control of the knee joint;
  • Patients whose weight, age or activity level might cause extreme loads and early failure of the system.

Key Trial Info

Start Date :

July 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2020

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT03354195

Start Date

July 1 2018

End Date

January 30 2020

Last Update

February 5 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Florida Orthopaedic Institute

Tampa, Florida, United States, 33637